TP53 and pancreatic neoplasm: Previously, work from Wang and others identified a 7-[anilino(phenyl)methyl]-2-methyl-8-quinolinol based compound that inhibited the MDM2-p53 interaction in pancreatic cancer cell lines [34, 35].